Xofluza在流感治疗方面获得了优于Tamiflu的优势,因为其恢复速度更快,耐受性更好,尽管它有局限性,成本也更高。 Xofluza is gaining favor over Tamiflu for flu treatment due to faster recovery and better tolerability, though it has limitations and higher cost.

Xofluza是一种单剂量抗病毒药物,由于可耐性强和病毒传播速度快,在流感治疗方面比塔菲鲁人更受青睐,尽管它可能导致腹泻,而且抗药性在幼儿中更为普遍。 Xofluza, a one-dose antiviral, is increasingly preferred over Tamiflu for flu treatment due to better tolerability and faster viral shedding, though it may cause diarrhea and resistance is more common in young children. 对于孕妇,严重免疫功能低下患者或住院患者,不建议使用,因为Tamiflu仍然是首选药物. It’s not recommended for pregnant individuals, severely immunocompromised patients, or hospitalized cases, where Tamiflu remains the preferred choice. 所有抗病毒药物在出现症状后两天内效果最好,并且可以将疾病缩短几天。 All antivirals work best within two days of symptoms and can shorten illness by a few days. 获得保险的机会和费用各不相同,Xofluza在没有保险的情况下高达200美元。 Access and cost vary, with Xofluza reaching up to $200 without insurance. 专家们呼吁对重度流感病例的综合疗法进行更多的研究。 Experts are calling for more research on combination therapies for severe flu cases.